Today’s Top Three in Pharma 040209 posted on April 2, 2009Solvay shopping its drug business. Belgian conglomerate Solvay is eying an exit of the drug business with a sale of its pharmaceutical division that could be worth upwards of €5 billion, or $6.6 …Continue Reading about Today’s Top Three in Pharma 040209 →